IP Library Granted Patent US 9,931,366
Granted Patent B2
US 9,931,366 · App. 14/831,621 · Granted Apr 3, 2018

Topical pharmaceutical bases for wound and scar treatment

Inventor: Daniel Banov (Sugar Land, TX)
Assignee: Professional Compounding Centers of America
A61K36/58A61K9/0014A61K36/185A61K36/49A61K45/06A61L15/40A61L26/0057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,931,366
App. No.
14/831,621
Granted
Apr 3, 2018
Kind
B2
Abstract

The present disclosure refers to topical pharmaceutical bases that include a synergistic combination of pracaxi oil, andiroba oil, copaiba balsam, and ucuuba butter. Further, these topical pharmaceutical bases are proposed for treating skin conditions in mammals, such as, for example wounds and scars. The topical pharmaceutical bases provide healing, moisturizing, anti-inflammatory, antibacterial, and antifungal effect. Additionally, the topical pharmaceutical bases enable an effective administration of specific active pharmaceutical ingredients (APIs), thereby improving treatment outcomes. Topical pharmaceutical compositions including the topical pharmaceutical bases increase the residence time of APIs within a wound or scar, thereby improving the penetration of APIs into the affected area. Also, the topical pharmaceutical bases provide relatively uniform distribution of the APIs within the topical pharmaceutical compositions. Further, the topical pharmaceutical compositions release APIs slowly, thereby enhancing treatment effectiveness.

Claims (4)

1. A topical pharmaceutical composition comprising a pharmaceutically effective amount of at least one active pharmaceutical ingredient, and a synergistically effective amount of about 5% w/w to about 50% w/w ucuuba butter, about 5% w/w to about 50% w/w copaiba balsam, about 5% w/w to about 50% w/w andiroba oil, and about 5% w/w to about 50% w/w pracaxi oil.

2. The topical pharmaceutical composition of claim 1 further comprising at least one natural component selected from the group consisting of buriti oil, bacaba oil, acai oil, ojon oil, murumuru butter, and tucuma oil.

3. The topical pharmaceutical composition of claim 1 further comprising at least one natural component selected from the group consisting of about 1% w/w to about 20% w/w buriti oil, about 1% w/w to about 20% w/w bacaba oil, about 1% w/w to about 20% w/w acai oil, about 1% w/w to about 20% w/w ojon oil, about 1% w/w to about 20% w/w murumuru butter, and about 1% w/w to about 20% w/w tucuma oil.

4. The topical pharmaceutical composition of claim 1 further comprising at least one natural component selected from the group consisting of about 5% w/w buriti oil, about 5% w/w bacaba oil, about 5% w/w acai oil, about 5% w/w ojon oil, about 5% w/w murumuru butter, and about 5% w/w tucuma oil.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2016
From: BANOV, DANIEL
To: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA)
Reel/Frame 038216/0593 →
Continuity (2)
Provisional Application 62039797 · Aug 20, 2014
Related Publication 20160051611A1 · Feb 25, 2016